| Name | Tivanisiran |
|---|
| Description | Tivanisiran (SYL1001) is a siRNA used for the study of dry eye disease. Tivanisiran was designed to silence transient receptor potential vanilloid 1 (TRPV1)[1]. |
|---|---|
| Related Catalog | |
| In Vitro | In vitro transfection of tivanisiran was shown to produce a 50-60% decrease in TRPV1 mRNA levels[1][2]. |
| References |
[1]. Anne-Marie Bleau, et al. Development of tivanisiran, a topical siRNA designed to |
| No Any Chemical & Physical Properties |